Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease

Sponsor
Tianjin Medical University
Study ID
NCT07685873
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • Diagnostic Test: 18F-FPyCO/SMBT-1 — DIAGNOSTIC_TEST
    Each subject receive a single intravenous injection of 18F-FPyCO/SMBT-1, and undergo PET/ CT or MRI imaging within the specificed time.

Study Details

To evaluate the potential usefulness of 18F-FPyCO/SMBT-1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-B-related disease patients.

Key Dates

First listed
Jul 6, 2026
Start date
Jun 25, 2026
Status verified
Jun 2026
Primary completion
Jul 1, 2029
Completion
Jul 1, 2029

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Single Group Assignment
    Each subject receive a single intravenous injection of 18F-FPyCO/SMBT-1, and undergo PET/CT or MRI imaging within the specificed time.

Primary Outcome Measure

Standardized uptake value (SUV) [ Time Frame: 30 days ]

Central Contacts

Find similar trials

Nationwide
Parkinson's disease trialsNeurology trialsBrain disorders trials

Related Studies